Zeke Capital Advisors, LLC Charles River Laboratories International, Inc. Transaction History

Zeke Capital Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $428,311 - $541,122	-1,456 Closed	0 $0
Q1 2021 Apr 21, 2021	SELL	$249.67 - $299.48 $44,690 - $53,606	-179 Reduced 10.95%	1,456 $422,000
Q4 2020 Feb 10, 2021	BUY	$222.0 - $252.62 $71,928 - $81,848	324 Added 24.71%	1,635 $409,000
Q3 2020 Nov 09, 2020	SELL	$175.56 - $226.45 $24,578 - $31,703	-140 Reduced 9.65%	1,311 $297,000
Q2 2020 Jul 21, 2020	BUY	$118.84 - $189.72 $172,436 - $275,283	1,451 New	1,451 $253,000
Q1 2020 Apr 24, 2020	SELL	$98.9 - $178.34 $446,236 - $804,670	-4,512 Closed	0 $0
Q1 2019 Apr 29, 2019	SELL	$104.82 - $146.73 $438,357 - $613,624	-4,182 Reduced 48.1%	4,512 $655,000
Q4 2018 Feb 11, 2019	BUY	$105.09 - $137.23 $913,652 - $1.19 Million	8,694 New	8,694 $984,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Zeke Capital Advisors, LLC with notifications on news.